FIGURE

Fig. 4

ID

ZDB-FIG-250827-37

Publication

Zhang et al., 2025 - IL-23 Receptor Agonism by Mulberroside C Activates the RASGRP1/RAS/ERK Pathway Contributing to Leukopenia Treatments

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

The therapeutic effect of Mulberroside C (MC) on leukopenia mice. (A) Timeline of the KM mice intervention protocol. Effect of MC (2–8 mg/kg) or granulocyte colony-stimulating factor (G-CSF, 25 μg/kg) in irradiated or cyclophosphamide-treated KM mice. In irradiated KM mice, n = 8, (B) peripheral white blood cell counts, (C) peripheral neutrophil counts, (D) peripheral monocyte counts, and (E) peripheral lymphocyte counts. In cyclophosphamide-treated KM mice, n = 6, (F) peripheral white blood cell counts, (G) peripheral neutrophil counts, (H) peripheral monocyte counts, and (I) peripheral lymphocyte counts. Data are expressed as the mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 versus the model group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Phytother. Res.